Pharmacometrics (eBook, PDF)

The Science of Quantitative Pharmacology
Redaktion: Ette, Ene I.; Williams, Paul J.

• Format: PDF

Produktbeschreibung

Pharmacometrics is the science of interpreting and describing pharmacology in a quantitative fashion. The pharmaceutical industry is integrating pharmacometrics into its drug development program, but there is a lack of and need for experienced pharmacometricians since fewer and fewer academic programs exist to train them. Pharmacometrics: The Science of Quantitative Pharmacology lays out the science of pharmacometrics and its application to drug development, evaluation, and patient pharmacotherapy, providing a comprehensive set of tools for the training and development of pharmacometricians. Edited and written by key leaders in the field, this flagship text on pharmacometrics: * Integrates theory and practice to let the reader apply principles and concepts. * Provides a comprehensive set of tools for training and developing expertise in the pharmacometric field. * Is unique in including computer code information with the examples. This volume is an invaluable resource for all pharmacometricians, statisticians, teachers, graduate and undergraduate students in academia, industry, and regulatory agencies.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: John Wiley & Sons
• Seitenzahl: 1232
• Erscheinungstermin: 20. August 2007
• Englisch
• ISBN-13: 9780470087961
• Artikelnr.: 37290244

Autorenporträt

ENE I. ETTE, PhD, is a Fellow of the American Colleges of Clinical Pharmacy and Clinical Pharmacology. He is the President/CEO of Anoixis Corp. and was formerly the senior director and head of clinical pharmacology at Vertex Pharmaceuticals, Inc. He is also an adjunct professor of applied pharmaceutical sciences at the University of Rhode Island. Dr. Ette was a pioneer pharmacometric staff in the Office of Clinical Pharmacology and Biopharmaceutics at the Food and Drug Administration, where he developed the popular reference Guidance for Industry: Population Pharmacokinetics. From 1989 -2001, he was an FDA Consultant. In recognition of his contributions to clinical pharmacy and clinical pharmacology, Dr. Ette is the recipient of The American College of Clinical Pharmacy's Russell Miller Award. He is also the 2006 recipient of The American College of Clinical Pharmacy's Therapeutic Frontiers Lecture Award. Dr. Ette is chairman of the pharmacometrics panel of The Annals of Pharmacotherapy editorial board. PAUL J. WILLIAMS, PharmD, is a Fellow of the American Colleges of Clinical Pharmacy and Clinical Pharmacology and Professor of Pharmaceutical Sciences and Pharmacy Practice at the Thomas J. Long School of Pharmacy and Health Sciences. Dr. Williams is the Vice President, Strategic Consulting, West Coast Operations in Anoixis Corp. and was formerly a partner at Trials by Design, LLC, a clinical consulting company, and member of the editorial board for The Annals of Pharmacotherapy. Dr. Williams is the 2006 winner of the University of the Pacific Faculty Research Award, the Long's Faculty Fellowship, and Teacher of the Year.

Inhaltsangabe

Dedication.
Preface.
Acknowledgements.
Introduction.
Chapter 1. Pharmacometrics: Impacting Drug Development and Pharmacotherpay.
I: GENERAL PRINCIPLES.
Chapter 2. General Principles of Programming (Computer and Statistical).
Chapter 3. Validation of Software for Pharmacometric Analyses.
Chapter 4. Linear, Generalized Linear, and Nonlinear Mixed-Effects Models.
Chapter 5. Bayesian Hierarchical Modeling with Markov Chain Monte Carlo
Methods.
Chapter 6. Estimating the Dynamics of Drug Regimen Compliance.
Chapter 7. Graphical Display for Modeling Population Data.
Chapter 8. The Epistemology of Pharmacometrics.
Chapter 9. Data Imputation.
II: POPULATION PHARMACOKINETIC BASIS OF PHARMACOMETRICS.
Chapter 10. Population Pharmacokinetic Estimation Methods.
Chapter 11. Timing and Efficiency in Population Pharmacokinetic /
Pharmacodynamic Data Analysis.
Chapter 12. Designing Population Pharmacokinetic Studies for Efficient
Parameter Estimation.
Chapter 13. Population Models for Drug Absorption and Entero-hepatic
Recycling.
Chapter 14. Pharmacometric Knowledge Discovery from Clinical trial Data
Sets.
Chapter 15. Resampling Techniques and Their Application to Pharmacometrics.
Chapter 16. The Population Approach to Bioequivalence.
III: PHARMACOKINETICS / PHARMACODYNAMICS RELATIONSHIP BIOMARKERS AND
PHARMACOGENOMICS.
Chapter 17. Biomarkers in Drug Development and Pharmacometric Modeling.
Chapter 18. Analysis of Gene Expression Data.
Chapter 19. Pharmacogenomics and Pharmacokinetic/Pharmacodynamic Modeling.
Chapter 20. Empirical Pharmacokinetic/Pharmacodynamic Models.
Chapter 21. Developing Models of Disease Progression.
Chapter 22. Mechanistic Pharmacokinetic/Pharmacodynamic (PK/PD) Models.
Chapter 23. Mechanistic Pharmacokinetic/Pharmacodynamic Models II.
Chapter 24. PK/PD Analysis of Binary (Logistic) Outcome Data.
Chapter 25. Population Pharmacokinetic / Pharmacodynamic Modeling of
Ordered Categorical Longitudinal Data.
Chapter 26. Transition Models in Pharmacodynamics.
Chapter 27. Mixed Effects Modeling of Count Data.
Chapter 28. Mixture Modeling with NONMEM.
IV. CLINICAL TRIAL DESIGNS.
Chapter 29. Designs for First Time-in-Man Studies in Non-Oncology
Indications.
Chapter 30. Design for Phase I Studies in Oncology.
Chapter 31. Design and Analysis of Clinical Exposure - Response Trials.
V. PHARMACOMETRIC KNOWLEDGE CREATION.
Chapter 32. Pharmacometric Knowledge Creation: Towards Characterizing an
Unexplored Region of the Response Surface.
Chapter 33. Clinical Trial Simulation: Theory.
Chapter 34. Modeling and Simulation: Planning and Execution.
Chapter 35. Clinical Trial Simulation: Efficacy Trials.
VI: PHARMACOMETRIC SERVICE AND COMMUNICATION.
Chapter 36. Engineering a Pharmacometrics Enterprise.
Chapter 37. Communication of Pharmacometric Analysis Outcome.
VII: SPECIFIC APPLICATIONS EXAMPLES.
Chapter 38. Pharmacometrics Applications in Population  Exposure-Response
Data for New Drug Development and Evaluation.
Chapter 39. Pharmacometrics in Pharmacotherapy and Drug Development:
Pediatric Application.
Chapter 40. Pharmacometric Methods for Assessing Drug-Induced QT and QTc
Prolongations for Non-Antiarrhythmic Drugs.
Chapter 41. Using Pharmacometrics in the Development of Biologic
Therapeutic Agents.
Chapter 42. Analysis of Quantic Pharmacokinetic Study: Robust Estimation of
Tissue-to-Plasma Ratio.
Chapter 43. Physiologically Based Pharmacokinetic Modeling: Inhalation,
Ingestion and Dermal Absorption.
Chapter 44. Modeling of Metablite Pharmacokinetics in a Large
Pharmacokinetic Data Set: An Application.
Chapter 45. Characterizing Nonlinear Pharmacokinetics: An Example Scenario
for a Therapeutic Protein.
Chapter 46. Development, Evaluation and Applications of In Vitro/ In Vivo
Correlations: A Regulatory Perspective.
Chapter 47. The Confluence of Pharmacometric Knowledge Discovery and
Creation in the Characterization of Drug Safety.

Rezensionen

"...this landmark text is the first to pull together and present in one volume the many facets of pharmacometrics." ( American Journal of Pharmaceutical Education , Vol 71, No. 4, 2007)